eliemtx.com (ELYM) Narxning foydaga nisbati
Neyropsixiatrik vositalarning ishlab chiqilishidagi kechikishlar xavfi va moliyaviy mablag‘lar yetishmovchiligi qisman birlashish kelishuvlari bilan qoplangan. -5.40 indikatori bilan savdo dinamikasini aks ettiruvchi ushbu narxlar grafigi, bonuslar orqali yetakchi neyrobiologlarni jalb qilish va yuqori rahbariyatning ilmiy ekspertizasi bo‘yicha ma’lumotlarni to‘ldiradi. Eliem Therapeutics (ELYM) organizmga yumshoqroq ta’sir qiluvchi depressiya va surunkali og‘riqlarga qarshi innovatsion dori vositalarini yaratishga tayanadi.
eliemtx.com (ELYM) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Eliem Therapeutics, Inc.|ELYM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Eliem Therapeutics|Shoshilinch likvidlik eliemtx.com
- foyda va bozor multiplikatorlari tafsilotlari:
ELYM - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Eliem Therapeutics|ELYM - P/E multiplikatori|Forvard P/E multiplikatori eliemtx.com|ELYM - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Eliem Therapeutics, Inc.|ELYM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Eliem Therapeutics|ELYM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi eliemtx.com|ELYM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Eliem Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning umumiy tahlili:Eliem Therapeutics Inc., ELYM
P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi va investorlarning joriy daromadlar uchun qanchalik ortiqcha to'lov qilayotganini o'lchaydi. Yuqori qiymatlar kengayish kutayotganini signalizatsiya qiladi, past qiymatlar esa aktivning qadrsizlanganini yoki xatarlarni ko'rsatadi. Emitentning P/E dinamikasini tahlil qilish orqali kelajakdagi o'sish sur'atlariga tegishli kapital kayfiyatidagi o'zgarishlarni kuzatish mumkin. Eliem Therapeutics (ELYM) uchun ushbu ko'rsatkich barqaror qolmoqda, chunki nevrologik patologiyalar uchun dori vositalarini ishlab chiqish iste'mol sikllariga bog'liq emas.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea|Narx-foyda multiplikatori CRGT (Cortigent)|Narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Narx-foyda koeffitsiyenti|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
